Medtronic Launches 722 Real-time Insulin Pump System In China
This article was originally published in PharmAsia News
Medtronic (Shanghai) Management Co., Ltd. has launched its 722 Real-time Insulin Pump System in China.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.